1. Doll R, Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (66): 1191–1308, 1981.
2. Parkes HG: The epidemiology of aromatic amine cancers. In: CE Searle (ed) Chemical Carcinogens, Monograph No. 173. American Chemical Society, Washington, DC, 1976, pp 462–480.
3. King CM, Wang CY, Lee M-S, Vaught JB, Hirose M, Morton KC: Metabolic activation of aromatic amines and the induction of liver, mammary gland and urinary bladder tumors in the rat. In: Rydstrom J, Montelius J, Bengtsson M (ed) Extrahepatic Drug Metabolism and Chemical Carcinogenesis. Elsevier Science Publishers, Amsterdam, 1983, pp 557–566.
4. Gilden RV, Rice NR: Oncogenes. Carcinogenesis (4): 791–794, 1983.
5. Sesnowitz-Horn S, Adelberg A: Proflavin treatment of E. Coli generation of frameshift mutants. Cold Spring Harbor Symp Quant Biol (33): 393–402, 1968.